On the Record · Abiomed
Abiomed acquisitions, on the record
The businesses Abiomed bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Breethe, Inc.Word for word“We acquired Breethe, Inc. (“Breethe”), a Maryland corporation, on April 24, 2020.” 10-K for 2020 | agreed acquisition | April 24, 2020 | — |
ECP Entwicklungsgesellschaft mbH and AIS GmbH Aachen Innovative SolutionsWord for word“The Company acquired ECP and AIS for $ 13.0 million in cash, with additional potential payouts totaling $ 15.0 million based on the achievement of CE Mark approval in the European Union and a revenue-based milestone related to the development of the future Impella ECP™ expandable catheter pump technology.” 10-K for 2020 | acquisition | — | $ 13.0 million in cash, with additional potential payouts totaling $ 15.0 million |
Impella Cardio Systems AGWord for word“Share Purchase Agreement for the acquisition of Impella Cardio Systems AG, dated April 26, 2005” 10-K for 2020 | acquisition | — | — |
AIS GmbH Aachen Innovative SolutionsWord for word“Agreement on the Sale and Transfer of all shares in AIS GmbH Aachen Innovative Solutions 8-K (File No. 001-09585) July 7, 2014 2.2” 10-K for 2020 | divestiture | July 7, 2014 | — |
ECP and AIS GmbH Aachen Innovative Solutions ("AIS")Word for word“In July 2014, the Company acquired ECP and AIS GmbH Aachen Innovative Solutions (“AIS”) for $ 13.0 million in cash, with additional potential payouts totaling $ 15.0 million based on the achievement of CE Mark approval in the European Union and a revenue-based milestone related to the development of the future Impella ECP TM expandable catheter pump technology.” 10-K for 2021 | acquisition | July 2014 | $ 13.0 million in cash |
Impella Cardiosystems AGWord for word“The carrying amount of goodwill as of March 31, 2021 and 2020 was $ 78.6 million and $ 32.0 million, respectively, and has been recorded in connection with the Company’s acquisition of Impella Cardiosystems AG, in May 2005, ECP in July 2014 and Breethe in April 2020.” 10-K for 2021 | acquisition | May 2005 | — |
preCARDIA, Inc.Word for word“The Company acquired preCARDIA for a purchase price of $ 115.2 million.” 10-K for 2022 | acquisition | — | $ 115.2 million |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) |
|---|---|
| 2021-03-31 | $52.2 million |
Deal filings since 2016
- 2022-12-22 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2022-11-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-08-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-09-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-08-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Abiomed’s annual reports (10-K for 2022, 10-K for 2021, 10-K for 2020) and the financial data it files with the SEC, as of 2022-05-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.